Drug reaction with eosinophilia and systemic symptoms (DReSS), also known as drug-
induced hypersensitivity syndrome (DiHS), is an uncommon severe adverse reaction to …

Background: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but
life-threatening adverse drug reaction. Several criteria have been established to aid the …

A prompt recognition of life-threatening and severe acute rashes is of utmost importance to
start an appropriate therapy as soon as possible. Consequently, clinicians often must rely …

Objective: Exanthema in drug reaction with eosinophilia and systemic symptoms (DRESS)
has no specific clinical diagnostic hallmark and there are few histopathologic studies. The …

Severe life‐threatening cutaneous drug reactions are rare phenomena, and may be
clinically heterogeneous. They may be broadly categorized as Stevens–Johnson syndrome …

The diagnosis of coronavirus disease (COVID-19) has been a great challenge since the
infection affects not only the respiratory system, but also different organs, given the intense …

Background: The data on the histology of cutaneous lesions of drug reaction with
eosinophilia and systemic symptoms (DRESS) is limited. Aims: To study the histopathology …

DRESS is a potentially life-threatening severe cutaneous adverse reaction (SCAR).
Historically, it was most frequently linked with phenytoin and was initially described as …

A 28 year old Afro-Caribbean woman presented to our hospital with a three day history of an
acute, diffuse, urticarial, papular rash on her trunk, limbs, and face. She also had facial …

Non-immediate drug reactions (NIR) are induced by specific immunological mechanisms
and involve the recognition of hapten molecules by the immune system, with the …